TW201302243A - Skin-improving agent for oral intake - Google Patents
Skin-improving agent for oral intake Download PDFInfo
- Publication number
- TW201302243A TW201302243A TW101120223A TW101120223A TW201302243A TW 201302243 A TW201302243 A TW 201302243A TW 101120223 A TW101120223 A TW 101120223A TW 101120223 A TW101120223 A TW 101120223A TW 201302243 A TW201302243 A TW 201302243A
- Authority
- TW
- Taiwan
- Prior art keywords
- skin
- extract
- emblica
- improving agent
- wrinkles
- Prior art date
Links
- 230000037303 wrinkles Effects 0.000 claims abstract description 36
- 239000000284 extract Substances 0.000 claims abstract description 30
- 230000037319 collagen production Effects 0.000 claims abstract description 23
- 235000013305 food Nutrition 0.000 claims abstract description 22
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims abstract description 10
- 244000077923 Vaccinium vitis idaea Species 0.000 claims abstract description 10
- 230000037406 food intake Effects 0.000 claims description 26
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 23
- 230000001737 promoting effect Effects 0.000 claims description 8
- 244000119298 Emblica officinalis Species 0.000 claims 4
- 230000037393 skin firmness Effects 0.000 abstract description 2
- 229940037003 alum Drugs 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 description 27
- 230000000694 effects Effects 0.000 description 27
- 238000012360 testing method Methods 0.000 description 27
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 25
- 244000078534 Vaccinium myrtillus Species 0.000 description 25
- 240000009120 Phyllanthus emblica Species 0.000 description 19
- 238000000034 method Methods 0.000 description 15
- 235000013399 edible fruits Nutrition 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 102000008186 Collagen Human genes 0.000 description 9
- 108010035532 Collagen Proteins 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 241001122767 Theaceae Species 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000001061 forehead Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 239000000902 placebo Substances 0.000 description 5
- 229940068196 placebo Drugs 0.000 description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 description 4
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 4
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 4
- 235000004634 cranberry Nutrition 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001130943 Phyllanthus <Aves> Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000208421 Ericaceae Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 244000166124 Eucalyptus globulus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010162 Tukey test Methods 0.000 description 2
- 235000012511 Vaccinium Nutrition 0.000 description 2
- 241000736767 Vaccinium Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 229940102480 bilberry extract Drugs 0.000 description 2
- 235000019209 bilberry extract Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940114371 lingonberry extract Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- -1 rice starch Polymers 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 244000003240 Caesalpinia gilliesii Species 0.000 description 1
- 235000014161 Caesalpinia gilliesii Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000119461 Garcinia xanthochymus Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 235000015742 Nephelium litchi Nutrition 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000011472 cat’s claw Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- BTAAXEFROUUDIL-UHFFFAOYSA-M potassium;sulfamate Chemical compound [K+].NS([O-])(=O)=O BTAAXEFROUUDIL-UHFFFAOYSA-M 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
本發明係關於一種含有越橘(Vaccinium vitis-idaea)及餘甘子(Phyllanthus emblica或Emblica officinale)之植物體或其萃取物的經口攝取用肌膚改善劑、經口攝取用膠原蛋白產生促進劑、及飲食品。 The present invention relates to a skin improving agent for oral ingestion of a plant body or an extract thereof containing Vaccinium vitis-idaea and Phyllanthus emblica or Emblica officinale, or a collagen production promoter for oral ingestion, And food and beverage products.
近年來,作為女性美容方面之煩惱,有隨著年齡增長而皮膚之皺紋或鬆弛增加之問題。並且,已知此種皮膚之皺紋或鬆弛係由於皮膚纖維母細胞之膠原蛋白產生能力降低而引起。 In recent years, as an annoyance of women's beauty, there has been a problem that wrinkles or slack of the skin increase with age. Further, it is known that wrinkles or slacks of such skin are caused by a decrease in collagen production ability of skin fibroblasts.
因此,為了促進膠原蛋白之產生,不斷開發了調配有各種植物萃取物之皮膚外用劑(專利文獻1),於皮膚外用劑中,有效成分係經皮吸收而應用於纖維母細胞中,因此根據有效成分之不同,有時於皮膚中之吸收性成為問題,未必能獲得充分之效果。 Therefore, in order to promote the production of collagen, an external preparation for skin containing various plant extracts has been developed (Patent Document 1). In the external preparation for skin, the active ingredient is percutaneously absorbed and applied to fibroblasts. The difference in active ingredients sometimes causes problems in the absorption of the skin, and may not necessarily achieve sufficient effects.
另一方面,於像食品等般經口攝取之情形時,係直接攝入至體內,故而與外用方式之應用相比有效成分容易吸收,可期待充分之效果。 On the other hand, in the case of oral ingestion like food, it is directly ingested into the body, so that the active ingredient is easily absorbed compared with the application of the external method, and a sufficient effect can be expected.
作為可提高膠原蛋白之產生能力之食品,已知有含有餘甘子之萃取物的膠原蛋白產生促進劑(專利文獻2),業界期待藉由於其中添加其他成分,而開發出一種可進一步促進膠原蛋白之產生,提高不僅面部而是全身之肌膚之緊致感或光滑度,使皺紋或法令紋變得不明顯的肌膚改善效 果較高之經口攝取用之肌膚改善劑。 A collagen production promoter containing an extract of Phyllanthus emblica is known as a food capable of improving collagen production (Patent Document 2), and the industry is expected to further promote collagen by adding other components. Produces and improves the firmness or smoothness of the skin not only on the face but on the whole body, but also improves the skin with wrinkles or striated lines that are not noticeable. A higher skin improving agent for oral intake.
再者,越橘(別名苔桃)之萃取物含有熊果苷,其可作用於酪胺酸酶中而抑制黑色素之合成,故而將其調配於食品等中的發揮美白效果之美容食品等已眾所周知(專利文獻3),但此種越橘(別名苔桃)之萃取物迄今為止尚不知曉與膠原蛋白產生能力相關之效果。 In addition, the extract of bilberry (alias moss) contains arbutin, which acts on tyrosinase to inhibit the synthesis of melanin, so it is well known that it is formulated into foods and the like to provide a whitening effect. (Patent Document 3), but such an extract of cranberry (alias moss) has not been known to have an effect related to collagen production ability.
[專利文獻1]日本特開2006-160629號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2006-160629
[專利文獻2]日本特開2008-156287號公報 [Patent Document 2] Japanese Patent Laid-Open Publication No. 2008-156287
[專利文獻3]日本特開2010-111590號公報 [Patent Document 3] Japanese Patent Laid-Open Publication No. 2010-111590
本發明之目的在於提供一種經口攝取而促進膠原蛋白產生能力從而改善肌膚之緊致感等的效果優異,且亦可持續經口攝取之源自天然且安全性較高的經口攝取用肌膚改善劑、經口攝取用膠原蛋白產生促進劑及飲食品。 An object of the present invention is to provide a natural and safe oral ingestion skin which is excellent in the effect of promoting the production of collagen by oral ingestion and improving the firmness of the skin. A improving agent, a collagen production promoting agent for oral ingestion, and a food or drink.
本發明者為了解決上述課題而進行銳意研究,結果發現,當持續地經口攝取杜鵑花科(Ericaceae)越橘屬(Vaccinium)之越橘(Vaccinium vitis-idaea)及大戟科(Euphorbiaceae)餘甘子屬(Emblica)之餘甘子(Phyllanthus emblica或Emblica officinale)之植物體或其萃取物時,可促進膠原蛋白之產生能力,藉此可表現出肌膚之緊致感或光滑度提高,皺紋或法令紋變得不明顯等改善肌膚之顯著效果,從而完成本發明。 The inventors of the present invention conducted intensive studies to solve the above problems, and as a result, found that Vaccinium vitis-idaea and Euphorbiaceae are continuously ingested by the Ericaceae (Vaccinium) of the Ericaceae family. The plant body of the genus Phyllantus (Emblicahus emblica or Emblica officinale) or its extract can promote the production of collagen, thereby showing the firmness or smoothness of the skin, wrinkles or decrees. The present invention is completed by the fact that the texture becomes inconspicuous and the like, and the remarkable effect of the skin is improved.
即,本發明係一種經口攝取用肌膚改善劑,其目的在於改善肌膚之緊致感、光滑度、皺紋及法令紋,其特徵在 於:含有越橘及餘甘子之植物體或其萃取物。 That is, the present invention is a skin improving agent for oral ingestion, which aims to improve skin firmness, smoothness, wrinkles and striated lines, and is characterized in that 于: A plant body containing bilberry and amla, or an extract thereof.
又,本發明係一種經口攝取用膠原蛋白產生促進劑,其特徵在於:含有越橘及餘甘子之植物體或其萃取物。 Further, the present invention relates to a collagen production promoter for oral ingestion, which comprises a plant body containing cranberry and emblica or an extract thereof.
又,本發明係一種飲食品,其特徵在於:含有上述之經口攝取用肌膚改善劑或經口攝取用膠原蛋白產生促進劑。 Moreover, the present invention relates to a food or drink comprising the above-mentioned orally ingested skin improving agent or orally ingesting collagen production promoting agent.
根據本發明之經口攝取用肌膚改善劑等,當持續地經口攝取時,膠原蛋白量增加、皮膚之彈性提高,藉此遍及全身之肌膚之緊致感或光滑度提高,皺紋或法令紋變得不明顯等,可改善由年齡增大所引起之肌膚老化。 According to the skin improving agent for oral ingestion of the present invention, when the oral ingestion is continued, the amount of collagen is increased, and the elasticity of the skin is increased, thereby improving the firmness or smoothness of the skin throughout the body, wrinkles or striated lines. It becomes less obvious, etc., which can improve skin aging caused by age.
又,本發明之經口攝取用肌膚改善劑等係含有可食用之天然植物之植物體或其萃取物作為有效成分,因此安全性較高,可實現持續之攝取,且可根據各種愛好而設定攝取時之形態,可用作飲食品或經口用醫藥品。 In addition, the skin improving agent for oral ingestion of the present invention contains an edible natural plant or an extract thereof as an active ingredient, and thus has high safety and can be continuously ingested, and can be set according to various preferences. The form at the time of ingestion can be used as a food or drink or an oral medicine.
本發明之經口攝取用肌膚改善劑等含有由可經口攝取之杜鵑花科越橘屬(Vaccinium)之越橘(Vaccinium vitis-idaea)及大戟科餘甘子屬(Emblica)之餘甘子(Phyllanthus emblica或Emblica officinale)獲得之植物體或其萃取物作為有效成分。 The skin improving agent for oral ingestion of the present invention contains Vaccinium vitis-idaea of the genus Vaccinium which can be orally ingested, and yam of the genus Emblica of the genus Eucalyptus (Emblica) A plant body obtained by Phyllanthus emblica or Emblica officinale or an extract thereof is used as an active ingredient.
越橘(Vaccinium vitis-idaea)別稱苔桃,於北歐之北極圈或加拿大大量地自然生長,已知其富含維生素C或檸檬酸。果實可生食,並且常用於果汁、果醬等加工食品中。 Vaccinium vitis-idaea, also known as moss, grows naturally in the Arctic Arctic Circle or Canada and is known to be rich in vitamin C or citric acid. The fruit can be eaten raw and is often used in processed foods such as juices and jams.
作為本發明所使用之越橘之部位,並無特別限定,可 任意使用果實(未成熟果實、成熟果實、乾燥果實)、葉、塊根、花、種子等。其中,較佳為使用果實。 The portion of the bilberry used in the present invention is not particularly limited, and The fruit (immature fruit, mature fruit, dried fruit), leaves, roots, flowers, seeds, and the like are used arbitrarily. Among them, it is preferred to use a fruit.
本發明所使用之越橘可直接使用新鮮之越橘,亦可使用經乾燥者,但就使用性、製劑化等之方面而言,較佳為以乾燥粉末或溶劑萃取物使用。 The bilberry used in the present invention may be directly used as a fresh bilberry, or may be dried. However, in terms of usability, formulation, and the like, it is preferably used as a dry powder or a solvent extract.
作為獲得乾燥粉末之方法,有將植物之各種部位(果實、葉、塊根、花、種子等)或全株細切或粉碎,其後進行乾燥之方法,或者將植物乾燥後細切或粉碎而獲得乾燥粉末之方法。又,亦可適宜採用將植物細切或粉碎,實施醱酵或酵素處理之後,進行乾燥,進而視需要加以粉碎以成為特定粒徑之方法等。 As a method of obtaining a dry powder, various parts of a plant (fruit, leaves, roots, flowers, seeds, etc.) or whole plants are finely cut or pulverized, followed by drying, or the plants are dried, finely cut or pulverized. A method of obtaining a dry powder. Further, a method in which the plant is finely cut or pulverized, subjected to fermentation or enzyme treatment, dried, and pulverized as necessary to obtain a specific particle diameter may be suitably used.
越橘之萃取物可根據通常之方法而獲得,例如,可藉由將越橘視需要乾燥之後,於萃取溶劑中浸漬固定時間,或者與加熱回流之萃取溶劑接觸,繼而過濾、濃縮而獲得。作為萃取溶劑,只要為通常萃取所使用之溶劑,則可任意使用,可分別單獨地或組合使用例如:水、甲醇、乙醇、丙二醇、1,3-丁二醇、甘油等醇類;氯仿、二氯乙烷、四氯化碳、丙酮、乙酸乙酯等有機溶劑。可將利用上述溶劑萃取所得之萃取液直接使用,或使用經濃縮之萃取物,或者使用將該等萃取物利用吸附法,例如使用離子交換樹脂去除雜質所得者,或利用多孔性聚合物(例如Amberlite XAD-2)之管柱進行吸附後,利用甲醇或乙醇溶出且進行濃縮而成者。又,亦可使用利用分配法,例如以水/乙酸乙酯萃取所得之萃取物等。越橘萃取物作為例如 「LINGONBERRY EXTRACT」(ORYZA OIL & FAT CHEMICAL股份有限公司製造)等有市售,亦可使用該等市售品。 The extract of bilberry can be obtained according to a usual method. For example, it can be obtained by immersing bilberry as needed, immersing it in an extraction solvent for a fixed period of time, or contacting with an extraction solvent heated under reflux, followed by filtration and concentration. The extraction solvent may be used arbitrarily as long as it is a solvent used for the usual extraction, and may be used alone or in combination, for example, an alcohol such as water, methanol, ethanol, propylene glycol, 1,3-butylene glycol or glycerin; chloroform; An organic solvent such as dichloroethane, carbon tetrachloride, acetone or ethyl acetate. The extract obtained by the above solvent extraction may be used as it is, or the concentrated extract may be used, or the extract may be obtained by an adsorption method, for example, using an ion exchange resin to remove impurities, or by using a porous polymer (for example, The column of Amberlite XAD-2) is adsorbed, and then dissolved and concentrated by methanol or ethanol. Further, an extract obtained by, for example, extraction with water/ethyl acetate by a distribution method, or the like can also be used. Bilberry extract as for example "LINGONBERRY EXTRACT" (manufactured by ORYZA OIL & FAT CHEMICAL Co., Ltd.) is commercially available, and these commercially available products can also be used.
本發明所使用之餘甘子(Phyllanthus emblica或Emblica officinale)係屬於大戟科餘甘子屬(Emblica)之落葉亞喬木,分佈於自印度至馬來西亞地區及中國南部,一般認為印度為原產地。餘甘子根據各地域或語言之不同而分別具有固有之名稱,例如亦可稱為:餘柑子、油柑、庵摩勒(Amalaka)、馬六甲樹(Pokok Melaka)、印度醋栗(Indian gooseberry)等。 The Phyllanthus emblica or Emblica officinale used in the present invention belongs to the deciduous sub-arbor of the genus Emblica of the genus Eucalyptus, which is distributed from India to Malaysia and southern China, and is generally considered to be the origin of India. Yu Ganzi has its own name according to the local language or language. For example, it can also be called: Yuganzi, citrus, Amalaka, Pokok Melaka, Indian gooseberry, etc. .
作為餘甘子之使用部位,並無特別限定,可任意地使用果實(未成熟果實、成熟果實、乾燥果實)、葉、塊根、花、種子等,其中較佳為使用果實。 The use site of the Phyllanthus emblica is not particularly limited, and the fruit (immature fruit, mature fruit, dried fruit), leaves, roots, flowers, seeds, and the like can be used arbitrarily. Among them, the fruit is preferably used.
餘甘子可直接使用新鮮之餘甘子,亦可使用經乾燥者,但就使用性、製劑化等之方面而言,較佳為以乾燥粉末或溶劑萃取物使用。用以獲得乾燥粉末或萃取物之方法並無特別限定,可採用上述越橘中所記載之方法。餘甘子萃取物例如由太陽化學股份有限公司以「SunAmla」等而市售,亦可使用該等市售品。 Phyllanthus emblica can be used directly as a fresh yam, or can be dried, but it is preferably used as a dry powder or a solvent extract in terms of usability, formulation, and the like. The method for obtaining a dry powder or an extract is not particularly limited, and the method described in the above bilberry can be employed. The Phyllanthus emblica extract is commercially available, for example, from Sun Chemical Co., Ltd. as "SunAmla", and the like, and these commercially available products can also be used.
本發明之經口攝取用肌膚改善劑等如實施例中所詳細敍述般,藉由促進纖維母細胞中之膠原蛋白產生能力而提高肌膚之彈性,結果發揮肌膚之緊致感或光滑度提高,皺紋或法令紋變得不明顯等抑制由年齡增大所引起之肌膚老化的效果。 The skin improving agent for oral ingestion of the present invention, as described in detail in the examples, enhances the elasticity of the skin by promoting the collagen production ability in the fibroblast, and as a result, the firmness or smoothness of the skin is improved. Wrinkles or striated lines become inconspicuous and inhibit the skin aging caused by age.
本發明之經口攝取用肌膚改善劑及經口攝取用膠原蛋白產生促進劑可調配於各種飲食品中,以肌膚改善用之食品之形態而攝取,另外亦可以醫藥製劑之形態而投予。 The skin improving agent for oral ingestion and the collagen production promoting agent for oral ingestion of the present invention can be incorporated into various foods and drinks, and can be ingested in the form of a food for improving the skin, and can also be administered in the form of a pharmaceutical preparation.
又,本發明之飲食品可藉由於各種飲食品中調配越橘及餘甘子之植物體或其萃取物而獲得,但於量產步驟中,亦可將上述經口攝取用肌膚改善劑或經口攝取用膠原蛋白產生促進劑製成半成品,將該半成品調配於各種飲食品中,藉此高效率地獲得具有肌膚改善效果之飲食品。 Moreover, the food or drink of the present invention can be obtained by blending a plant body of Bilberry and Phyllanthus emblica or an extract thereof in various foods and drinks, but in the mass production step, the above-mentioned oral skin improving agent or the like can also be used. A semi-finished product is prepared by using a collagen production accelerating agent for oral ingestion, and the semi-finished product is blended in various foods and drinks, thereby efficiently obtaining a food or drink having a skin-improving effect.
所攝取(投予)之越橘及餘甘子之量可根據攝取(投予)之方法或劑型等適當決定,較理想的是以將每一日之攝取(投予)量設為如下之方式進行製備:以乾燥質量換算越橘為0.1 mg~10 g,較佳為1~1000 mg,尤佳為10~100 mg,餘甘子為0.1 mg~10 g,較佳為1~1000 mg,尤佳為10~100 mg。 The amount of the bilberry and the yoghurt to be ingested (administered) can be appropriately determined according to the method of ingestion (administration) or the dosage form, and the like, and it is preferable to set the amount of ingestion (administration) per day as follows. Preparation: Bilberry is 0.1 mg~10 g, preferably 1~1000 mg, especially 10~100 mg, and 0.1 mg~10 g, preferably 1~1000 mg, especially in dry mass. Good for 10~100 mg.
於將本發明之經口攝取用肌膚改善劑或經口攝取用膠原蛋白產生促進劑調配於飲食品中之情形時,可視需要任意地選擇併用添加劑。作為添加劑,可包含功能性材料、賦形劑、呈味劑。 When the skin improving agent for oral ingestion of the present invention or the collagen production promoter for oral ingestion is formulated in a food or drink, the additive may be arbitrarily selected and used as needed. As an additive, a functional material, an excipient, and a flavoring agent may be included.
作為功能性材料,可列舉:泛酸、葉酸、生物素等各種維生素類;鋅、鈣、鎂、鐵等各種礦物質類;胺基酸、寡糖、蜂膠、蜂王漿、銀杏葉、薑黃、EPA(Eicosapentaenoic acid,二十碳五烯酸)、DHA(Docosahexaenoic acid,二十二碳六烯酸)、輔酶Q10、軟骨素、乳酸菌、乳鐵蛋白、異黃酮、西梅、甲殼素、聚葡萄胺糖、葡萄糖胺、α-硫辛酸、 巴西蘑菇(Agaricus)、藤黃果、蜂膠、膠原蛋白、蝦紅素、福斯高林(ForsLean)、兒茶素、芝麻素、神經醯胺、埃及野麻嬰(Corchorus olitorius)、螺旋藻(Spirulina)、貓爪草(Cat's Claw)等。該等功能性材料可單獨使用,或亦可組合兩種以上使用。 Examples of the functional material include various vitamins such as pantothenic acid, folic acid, and biotin; various minerals such as zinc, calcium, magnesium, and iron; amino acids, oligosaccharides, propolis, royal jelly, ginkgo biloba, turmeric, and EPA ( Eicosapentaenoic acid, eicosapentaenoic acid), DHA (Docosahexaenoic acid, docosahexaenoic acid), coenzyme Q10, chondroitin, lactic acid bacteria, lactoferrin, isoflavones, prunes, chitin, polyglucosamine Glucosamine, α-lipoic acid, Brazilian mushroom (Agaricus), Garcinia Cambogia, propolis, collagen, astaxanthin, ForsLean, catechin, sesamin, ceramide, Cochorus olitorius, Spirulina ), Cat's Claw, etc. These functional materials may be used singly or in combination of two or more.
作為賦形劑,只要為於製成所需之劑型時通常使用者即可,例如可列舉:小麥澱粉、米澱粉、玉米澱粉、馬鈴薯澱粉、糊精、環糊精等澱粉類;結晶纖維素類;乳糖、葡萄糖、砂糖、還原麥芽糖、飴糖、果寡糖、乳化寡糖等糖類;山梨糖醇、赤藻糖醇、木糖醇、乳糖醇、甘露醇等糖醇類。該等賦形劑可單獨使用,或可組合兩種以上使用。 The excipients are usually used as long as they are prepared into a desired dosage form, and examples thereof include starches such as wheat starch, rice starch, corn starch, potato starch, dextrin, and cyclodextrin; and crystalline cellulose. Types; sugars such as lactose, glucose, sucrose, reduced maltose, sucrose, fructooligosaccharides, emulsified oligosaccharides; sugar alcohols such as sorbitol, erythritol, xylitol, lactitol, and mannitol. These excipients may be used singly or in combination of two or more.
作為呈味劑,可列舉:文旦萃取物、荔枝萃取物、柚子萃取物等各種果汁萃取物;蘋果汁、橘子汁、檸檬汁等各種果汁;桃子香料、梅子香料、酸乳酪香料等各種香料;乙醯磺胺酸鉀、蔗糖素、赤藻糖醇、寡糖類、甘露糖、木糖醇、異構化糖類等各種甜味劑;檸檬酸、蘋果酸、酒石酸、葡萄糖酸等各種酸味劑;綠茶、烏龍茶、巴拿巴茶(Banaba tea)、杜仲茶、鐵觀音茶、薏苡茶、七葉膽茶、茭白茶、昆布茶等各種茶成分等。該等呈味劑可單獨使用,亦可組合兩種以上使用。 Examples of the flavoring agent include various juice extracts such as a denier extract, a lychee extract, and a grapefruit extract; various juices such as apple juice, orange juice, and lemon juice; various flavors such as peach flavor, plum flavor, and yoghurt flavor; Various sweeteners such as potassium sulfamate, sucralose, erythritol, oligosaccharides, mannose, xylitol, isomerized sugars; various sour agents such as citric acid, malic acid, tartaric acid, gluconic acid; Various tea ingredients such as oolong tea, Banaba tea, Eucommia tea, Tieguanyin tea, scented tea, safflower tea, scented white tea, and kelp tea. These flavoring agents may be used singly or in combination of two or more.
此外之著色劑、防腐劑、增黏劑、結合劑、崩解劑、分散劑、穩定劑、膠化劑、抗氧化劑、界面活性劑、防腐劑、pH值調整劑等可適當選擇食品等中所使用之公知者而使用。 In addition, a coloring agent, a preservative, a tackifier, a binder, a disintegrating agent, a dispersing agent, a stabilizer, a gelling agent, an antioxidant, a surfactant, a preservative, a pH adjusting agent, etc. may be appropriately selected from foods and the like. It is used by a publicly used person.
作為飲食品之形態,可任意選擇例如液體狀、固體狀、顆粒狀、粒狀、糊狀、凝膠狀等。 The form of the food or drink can be arbitrarily selected, for example, in the form of a liquid, a solid, a granule, a granule, a paste, or a gel.
作為飲食品之具體例,例如可列舉:果汁飲料、蔬菜汁、清涼飲料、茶等飲料類;湯、布丁、酸乳酪、蛋糕預混料製品、糕點類、餅乾、糖果、軟糖、口香糖等各種普通加工食品;另外,飲料劑等營養輔助飲食品、指定保健用飲食品、功能性飲食品、健康飲食品等。但是,並不限定於該等示例。 Specific examples of foods and drinks include juices, vegetable juices, refreshing drinks, and beverages such as tea; soups, puddings, yoghurts, cake premixes, cakes, biscuits, candies, soft candy, chewing gum, and the like. Various kinds of ordinary processed foods; nutritional supplement foods such as beverages, designated foods for health care, functional foods, and healthy foods and drinks. However, it is not limited to these examples.
將本發明之經口攝取用肌膚改善劑或經口攝取用膠原蛋白產生促進劑以醫藥製劑之形態而使用時,可適當地選擇劑型,例如可製成錠劑、顆粒劑、散劑、膠囊劑等固體製劑,或內服液劑、糖漿劑等經液體製劑等,於該等醫藥製劑中,亦可適當地使用通常所用之結合劑、崩解劑、增黏劑、分散劑、再吸收促進劑、矯味劑、緩衝劑、界面活性劑、溶解助劑、防腐劑、乳化劑、等張劑、穩定劑或pH值調整劑等賦形劑。 When the orally ingestible skin improving agent or the orally ingestible collagen production promoting agent of the present invention is used in the form of a pharmaceutical preparation, the dosage form can be appropriately selected, and for example, it can be used as a tablet, a granule, a powder, or a capsule. a solid preparation, or a liquid preparation such as an internal liquid preparation or a syrup preparation, etc., in which the usual use of a binding agent, a disintegrating agent, a viscosity increasing agent, a dispersing agent, and a resorption promoting agent may be appropriately used. Excipients such as flavoring agents, buffering agents, surfactants, dissolution aids, preservatives, emulsifiers, isotonic agents, stabilizers or pH adjusters.
以下,對為了確認本發明之效果而進行之試驗及結果更詳細地進行說明,但本發明並不限定於以下之試驗例或實施例。 Hereinafter, the test and the results performed to confirm the effects of the present invention will be described in more detail, but the present invention is not limited to the following test examples or examples.
1.將人真皮纖維母細胞播種至24孔板中,利用含有10%FBS之DMEM培養液連續進行培養。 1. Human dermal fibroblasts were seeded into 24-well plates and cultured continuously in DMEM medium containing 10% FBS.
2.確認形成為融合狀態之後,更換成包含各樣品之0.5 mL之DMEM培養液,於37℃下培養72小時。 2. After confirming that it was in a fused state, it was replaced with 0.5 mL of DMEM culture solution containing each sample, and cultured at 37 ° C for 72 hours.
3.培養後,使用ELISA法(Enzyme-linked immunosorbent assay,酵素結合免疫吸附分析法)測定培養液中之膠原蛋白濃度。 3. After the culture, the collagen concentration in the culture solution was measured by an enzyme-linked immunosorbent assay (Enzyme-linked immunosorbent assay).
樣品1:對照品 Sample 1: Reference
樣品2:餘甘子10 μg/mL Sample 2: Phyllanthus 10 μg/mL
樣品3:越橘10 μg/mL Sample 3: Bilberry 10 μg/mL
樣品4:越橘5 μg/mL+餘甘子5 μg/mL Sample 4: bilberry 5 μg/mL + emblica 5 μg/mL
餘甘子係使用太陽化學股份有限公司製造之「SunAmla」(商品名)。又,具有相同效果之萃取物(餘甘子萃取物)可使用熱水或水等極性溶劑,自作為使用部位之果實萃取獲得。 Yuganzi uses "SunAmla" (trade name) manufactured by Sun Chemical Co., Ltd. Further, the extract having the same effect (the extract of Phyllanthus emblica) can be obtained by extracting the fruit as a site of use using a polar solvent such as hot water or water.
越橘係使用ORYZA OIL & FAT CHEMICAL股份有限公司製造之「LINGONBERRY EXTRACT」(商品名)。又,具有相同效果之萃取物(越橘萃取物)可使用熱水或乙醇等極性溶劑,自作為使用部位之果實萃取獲得。 "The LINGONBERRY EXTRACT" (trade name) manufactured by ORYZA OIL & FAT CHEMICAL Co., Ltd. is used for the bilberry. Further, the extract (Bilberry extract) having the same effect can be obtained by extracting a fruit as a site of use using a polar solvent such as hot water or ethanol.
為了基於所收集之樣品驗證組間是否存在差異,進行統計處理。若檢驗結果顯示之顯著性概率(p)為5%(p<0.05),則認為檢驗中所使用之資料項目(稱為變數)間存在顯著差(significant difference)。若p未達10%(p<0.1),則認為檢驗時所使用之資料項目(稱為變數)間存在顯著之傾向差。產生顯著差及顯著之傾向差表示因某種原因而 產生差異。進行生物學試驗時,最終是否存在顯著差成為導出組間是否存在變化的方法。統計分析係利用Tukey法而實施。 In order to verify whether there is a difference between the groups based on the collected samples, statistical processing is performed. If the test results show a significance probability (p) of 5% (p < 0.05), it is considered that there is a significant difference between the data items (called variables) used in the test. If p is less than 10% (p < 0.1), there is a significant tendency difference between the data items (called variables) used in the test. Producing significant difference and significant propensity to indicate that for some reason Make a difference. When conducting a biological test, whether there is a significant difference in the end is a method of whether there is a change between the derived groups. Statistical analysis was carried out using the Tukey method.
圖1係表示上述樣品1~4之膠原蛋白產生能力之測定結果的圖。根據圖1之結果,確認到樣品4(調配有越橘及餘甘子)相對於樣品1(對照品)於膠原蛋白產生能力方面存在顯著差(p<0.001)。又,確認到樣品4(調配有越橘及餘甘子)與樣品2(單獨調配有餘甘子)相比於膠原蛋白產生能力方面存在傾向差(p<0.10)。據此,確認本發明之肌膚改善劑等藉由越橘與餘甘子之相乘效果,而增加膠原蛋白產生之效果優異。 Fig. 1 is a graph showing the results of measurement of the collagen production ability of the above samples 1 to 4. From the results of Fig. 1, it was confirmed that Sample 4 (with bilberry and Phyllanthus emblica) was significantly inferior to collagen 1 (control) in terms of collagen production ability (p < 0.001). Further, it was confirmed that Sample 4 (containing cranberry and emblica) was inferior to collagen 2 (p<0.10) in comparison with Sample 2 (with melon alone). According to this, it was confirmed that the skin improving agent of the present invention is excellent in the effect of increasing collagen production by multiplying the effect of cranberry and emblica.
繼而,由官能檢查員進行持續試驗,藉由以下所示之試驗確認本發明之效果。準備4種樣品,對於各樣品由15名官能檢查員進行持續服用試驗。官能檢查員藉由經口攝取1日1支地服用試驗試樣(飲料)8週。 Then, the test was carried out by a functional inspector, and the effects of the present invention were confirmed by the tests shown below. Four samples were prepared, and each sample was subjected to a continuous administration test by 15 functional inspectors. The functional inspector took the test sample (beverage) for one week by oral ingestion for one week.
將試驗試樣(飲料)之配方示於表1。 The formulation of the test sample (beverage) is shown in Table 1.
於持續服用試驗後(服用8週後),使用Cutometer(Courage+Khazaka公司製造)測定官能檢查員之背部皮膚之皮膚黏彈性。 The skin viscoelasticity of the back skin of the functional inspector was measured using a Cutometer (manufactured by Courage+Khazaka Co., Ltd.) after the continuous administration test (after 8 weeks of administration).
Cutometer係評價於固定壓力下吸引後之肌膚之變化的機器,可獲得如圖2所示之圖資料。圖中所示之R0~R8及F3之數值分別表示以下之物性。 The Cutometer is a machine for evaluating changes in the skin after being attracted under a fixed pressure, and the data shown in Fig. 2 can be obtained. The values of R0 to R8 and F3 shown in the figure indicate the following physical properties, respectively.
R0:拉伸容易度(以充分拉伸為佳數值越大越佳) R0: easy to stretch (better for full stretching) The bigger the value, the better)
R1:恢復至原位置之容易度(以恢復至原位置為佳數字較小為佳) R1: Ease of recovery to the original position (it is better to return to the original position) Smaller numbers are better)
R3:拉伸容易度(以充分拉伸為佳數字越大越佳) R3: easy to stretch (preferably full stretch) The bigger the number, the better)
R8(R0-R1):容易拉伸且容易恢復之效果之評價 數值越大越佳 R8 (R0-R1): Evaluation of the effect of easy stretching and easy recovery The bigger the value, the better
F3:上述包絡最大值(Envelope max)與最小值(min)之曲線(curve)之間的面積(相當於R8之累積)數值越大越佳 F3: the area between the above envelope maximum value (Envelope max) and the minimum value (min) curve (equivalent to the accumulation of R8) The bigger the value, the better
圖3~6係表示皮膚之黏彈性測定之結果的圖。D組(越橘+餘甘子)之皮膚之黏彈性效果優異,相對於A組(安慰劑)於黏彈性R0、R3、R8及F3上確認到顯著差。又,D組(越橘+餘甘子)相對於C組(越橘)於R8上確認到顯著差(p<0.05),於R0、R3及F3上確認到傾向差(p<0.10)。由此,確認本發明之肌膚改善劑等的提高皮膚之彈性,改善肌膚之緊致感等的效果優異。 Figures 3 to 6 are graphs showing the results of the measurement of the viscoelasticity of the skin. The skin of Group D (Bilberry + Phyllanthus emblica) had excellent viscoelastic effect, and a significant difference was confirmed on the viscoelasticity R0, R3, R8 and F3 with respect to Group A (placebo). Further, in the D group (Bilberry + Phyllanthus emblica), a significant difference (p < 0.05) was observed on R8 with respect to the C group (Bilberry), and a tendency difference (p < 0.10) was confirmed on R0, R3, and F3. In this way, it is confirmed that the skin improving agent of the present invention is excellent in the effect of improving the elasticity of the skin and improving the firmness of the skin.
於持續服用試驗開始日及持續服用試驗開始8週後(試驗結束日),拍攝眼角之照片。由皮膚科專科醫生,使用皺紋等級標準照片對各時間點之照片實施照片判定,以1/4值之得分進行評分。 Take a picture of the corner of the eye after the start of the continuous test and 8 weeks after the start of the continuous test (the end of the test). Photographs were taken from photographs at each time point by a dermatologist using a wrinkle rating standard photograph and scored on a 1/4 value score.
由服用前後之得分,藉由「皺紋改善度」=「試樣服用後之得分」-「試樣服用前之得分」之式而算出皺紋改善度。再者,關於組間差,實施曼-惠特尼(Mann-Whitney)之U檢驗。 From the scores before and after taking, the wrinkle improvement degree was calculated by the formula of "wrinkle improvement degree" = "score after sample taking" - "score before sample taking". Furthermore, regarding the difference between groups, a U-test of Mann-Whitney was carried out.
使用皺紋等級標準照片(皺紋等級為0~7之8個等級)(日本香妝品學會,化妝品功能評價法準則)實施視覺評 價,以1/4值之得分(例如3.25、3.5等)進行評分。皺紋判定係由皮膚科專科醫生實施。 Visual review using a standard photo of wrinkle grade (8 grades of wrinkle grade 0 to 7) (Japan Cosmetics Society, Guidelines for Cosmetic Function Evaluation) The price is scored by a score of 1/4 (for example, 3.25, 3.5, etc.). Wrinkle determination is performed by a dermatologist.
等級0:無皺紋 Level 0: no wrinkles
等級1:確認到些微不明顯之較淺之皺紋 Level 1: Confirm the slight wrinkles that are not obvious
等級2:確認到些微明顯之較淺之皺紋 Level 2: Confirm a slightly lighter wrinkle
等級3:確認到明顯之較淺之皺紋 Level 3: Obviously noticeable shallow wrinkles
等級4:於明顯之較淺之皺紋中,確認到些微稍深之皺紋 Level 4: Apparently slightly wrinkles in the apparently shallow wrinkles
等級5:確認到稍深之皺紋 Level 5: Confirm a deep wrinkle
等級6:確認到明顯且較深之皺紋 Level 6: Obvious and deep wrinkles confirmed
等級7:確認到非常深之皺紋 Level 7: Confirmation of very deep wrinkles
圖7係表示皺紋改善度之結果的圖。確認到D組(越橘+餘甘子)之肌膚之皺紋改善效果優異,相對於A組(安慰劑)存在顯著差(p<0.01)。又,確認到D組(越橘+餘甘子)相對於C組(越橘)亦存在傾向差(p<0.10)。由此,確認本發明之肌膚改善劑等的改善肌膚之皺紋之效果優異。 Fig. 7 is a view showing the result of wrinkle improvement. It was confirmed that the wrinkle improvement effect of the skin of the D group (Bilberry + Phyllanthus emblica) was excellent, and there was a significant difference (P<0.01) with respect to the A group (placebo). Further, it was confirmed that the D group (Bilberry + Phyllanthus emblica) had a tendency to be inferior to the C group (Bilberry) (p < 0.10). Thus, it was confirmed that the skin improving agent of the present invention is excellent in the effect of improving wrinkles of the skin.
於持續服用試驗開始日及試驗開始後1日後、3日後、7日後、14日後、28日後、56日後,針對「法令紋之明顯程度」、「額頭皺紋之明顯程度」、「肌膚之滑潤感」等實施問卷調查。 On the start date of the continuous use test and after 1 day, 3 days, 7 days, 14 days, 28 days, and 56 days after the start of the test, the "significant degree of the decree", "the apparent degree of the forehead wrinkles", "the smoothness of the skin" Conduct a questionnaire survey.
問卷調查係藉由作為評價尺度而通用之VAS(視覺類比尺度(visual analogue scale)之簡稱)進行評價。亦即,於各調查日,發給試驗者記載有劃為10 cm之一橫向直線的直線之用紙,將直線之左端設為「無實際感覺」,將右端設為「有實際感覺」,請試驗者將可實際感覺之程度記為直線上之位置(=試驗者於線段上之一部位附上標記),將以試驗開始之位置為基準向右側(或左側)移動之距離作為尺度值進行評價。再者,用以驗證組間差之統計分析係藉由Tukey法而實施。 The questionnaire was evaluated by VAS (short for visual analogue scale) which is a general evaluation scale. In other words, on each survey day, the tester was asked to record a line of paper that was drawn as a straight line of 10 cm. The left end of the line was set to "no actual feeling", and the right end was set to "have actual feeling". The tester records the degree of actual sensation as a position on a straight line (= the tester attaches a mark to a part of the line segment), and moves the distance moved to the right side (or the left side) based on the position at the start of the test as a scale value. Evaluation. Furthermore, the statistical analysis used to verify the difference between the groups was implemented by the Tukey method.
圖8係關於「法令紋」、圖9係關於「額頭之皺紋」、圖10係關於「肌膚之滑潤感」表示藉由問卷調查所得之改善度之結果的圖。圖中之*(p<0.05)、+(p<0.10)為相對於A組(安慰劑)可確認到顯著差或傾向差之部分。又,表2中係將於各調查日比較得出之組間之顯著差(p<0.05)、傾向差(p<0.10)分別以○、△表示。根據該等之結果,D組(越橘(RB)+餘甘子)的法令紋之改善、額頭之皺紋之改善、及肌膚之滑潤感之改善優異,且如圖8~10所示,於服用7日後,所有項目均可確認到相對於A 組(安慰劑)具有顯著差之效果。又,如表2所示,D組(越橘(RB)+餘甘子)相對於C組(越橘(RB))亦於法令紋、額頭之皺紋、及肌膚之滑潤感(光滑度)之改善效果方面確認到顯著差(p<0.05)或傾向差(p<0.10)。 Fig. 8 is a diagram showing the results of the improvement of the degree of improvement by "question pattern", Fig. 9 regarding "wrinkles on the forehead", and Fig. 10 on "smoothness of the skin". * (p < 0.05) and + (p < 0.10) in the figure are those in which a significant difference or a tendency is observed with respect to the group A (placebo). In addition, in Table 2, the significant difference (p<0.05) and the tendency difference (p<0.10) which are obtained by comparison on each investigation day are represented by ○ and Δ, respectively. Based on these results, the improvement of the descriptive lines of the D group (Bilberry (RB) + emblica), the improvement of wrinkles on the forehead, and the smoothness of the skin are excellent, and as shown in Figs. 8 to 10, After 7 days, all items were confirmed to have a significant difference with respect to group A (placebo). Further, as shown in Table 2, Group D (Bilberry (RB) + Phyllanthus) is also in the C group (Bilberry (RB)) in the wrinkles of the forehead, the wrinkles on the forehead, and the smoothness (smoothness) of the skin. A significant difference (p < 0.05) or a tendency (p < 0.10) was confirmed in terms of improvement effect.
圖11係表示服用56日後進行的關於手、臂之問卷調查的結果。於評價皮膚之老化的所有項目中,D組(越橘+餘甘子)均顯示出優異之改善效果,尤其是於「肌膚之水潤度」、「肌膚之光滑度」、「肌膚之光澤」、「枕頭痕跡之附著容易度」、「肌膚瘙癢」、「肌膚之透明感」方面,確認到相對於A組(安慰劑)具有顯著差*(p<0.05)或傾向差+(p<0.10)之改善效果。由此,可確認本發明之肌膚改善劑等對於面部以外之部位亦具有優異之肌膚改善效果。 Fig. 11 shows the results of a questionnaire survey on hands and arms performed 56 days after taking it. Among all the items for evaluating skin aging, Group D (Bilberry + Phyllanthus) showed excellent improvement effects, especially in "Water Moisture", "Skin Smoothness", "Skin Gloss" In the aspect of "easy adhesion of pillow marks", "skin itching", and "transparency of skin", it was confirmed that there was a significant difference * (p < 0.05) or a tendency difference (p < 0.10) with respect to group A (placebo). ) The improvement effect. Thus, it was confirmed that the skin improving agent of the present invention has an excellent skin-improving effect on a part other than the face.
p‧‧‧顯著性概率 p‧‧‧Significant probability
R0‧‧‧拉伸容易度 R0‧‧‧Ease of ease
R1‧‧‧恢復至原位置之容易度 R1‧‧‧Ease of returning to the original position
R3‧‧‧拉伸容易度 R3‧‧‧Ease of ease
R8‧‧‧容易拉伸且容易恢復之效果之評價 R8‧‧‧Evaluation of the effect of easy stretching and easy recovery
F3‧‧‧包絡最大值與最小值之曲線之間的面積 F3‧‧‧The area between the maximum and minimum curves of the envelope
圖1係表示使用人皮膚真皮纖維母細胞的膠原蛋白產生能力試驗之結果的圖。 Fig. 1 is a graph showing the results of a collagen production ability test using human skin dermal fibroblasts.
圖2係用以根據利用Cutometer所得之測定資料而導出黏彈性評價之指標的概念圖。 Fig. 2 is a conceptual diagram for deriving an index of viscoelasticity evaluation based on measurement data obtained by a Cutometer.
圖3係表示由黏彈性測定試驗所得之指標R0之數值的圖。 Fig. 3 is a graph showing the value of the index R0 obtained by the viscoelasticity measurement test.
圖4係表示由黏彈性測定試驗所得之指標R3之數值的圖。 Fig. 4 is a graph showing the value of the index R3 obtained by the viscoelasticity measurement test.
圖5係表示由黏彈性測定試驗所得之指標R8之數值的圖。 Fig. 5 is a graph showing the value of the index R8 obtained by the viscoelasticity measurement test.
圖6係表示由黏彈性測定試驗所得之指標F3之數值的 圖。 Figure 6 is a graph showing the value of the index F3 obtained by the viscoelasticity test. Figure.
圖7係表示眼角之皺紋之改善效果的圖。 Fig. 7 is a view showing an effect of improving the wrinkles of the corners of the eyes.
圖8係表示法令紋之改善效果的圖。 Fig. 8 is a view showing the effect of improving the ruled pattern.
圖9係表示額頭之皺紋之改善效果的圖。 Fig. 9 is a view showing an effect of improving wrinkles on the forehead.
圖10係表示肌膚之滑潤感之改善效果的圖。 Fig. 10 is a view showing an effect of improving the smoothness of the skin.
圖11係表示面部以外之部位(手、臂)的肌膚之改善效果的圖。 Fig. 11 is a view showing an effect of improving the skin of a part other than the face (hand, arm).
Claims (3)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011150116A JP4917180B1 (en) | 2011-07-06 | 2011-07-06 | Skin improver for ingestion |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201302243A true TW201302243A (en) | 2013-01-16 |
TWI586376B TWI586376B (en) | 2017-06-11 |
Family
ID=46243752
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW106103418A TW201720424A (en) | 2011-07-06 | 2012-06-06 | Skin-improving agent for oral intake |
TW101120223A TWI586376B (en) | 2011-07-06 | 2012-06-06 | Skin improvement methods and methods to promote collagen production |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW106103418A TW201720424A (en) | 2011-07-06 | 2012-06-06 | Skin-improving agent for oral intake |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4917180B1 (en) |
CN (1) | CN103648514B (en) |
TW (2) | TW201720424A (en) |
WO (1) | WO2013005514A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4917180B1 (en) * | 2011-07-06 | 2012-04-18 | 株式会社 資生堂 | Skin improver for ingestion |
JP5777209B2 (en) * | 2011-08-12 | 2015-09-09 | 株式会社 資生堂 | Collagen production promoter and food composition |
JP2015096488A (en) * | 2013-10-10 | 2015-05-21 | 康二 嘉島 | Method for inhibiting production of advanced glycation endproducts |
JP6332941B2 (en) * | 2013-11-01 | 2018-05-30 | 株式会社東洋発酵 | Oral composition for beauty health |
JP6397550B1 (en) * | 2017-09-12 | 2018-09-26 | 株式会社 資生堂 | Constitution improver |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1210016A (en) * | 1997-08-29 | 1999-03-10 | 王树岐 | Anti-cigarette health-care products |
FR2814950B1 (en) * | 2000-10-05 | 2003-08-08 | Oreal | USE OF AT LEAST ONE EXTRACT OF AT LEAST ONE PLANT FROM THE ERICACEAE FAMILY, IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING |
JP2003012531A (en) * | 2001-07-06 | 2003-01-15 | Ichimaru Pharcos Co Ltd | Collagenease activity inhibitor or cosmetic composition |
JP2005306850A (en) * | 2004-03-24 | 2005-11-04 | Kose Corp | Antidermopathic agent and skin lotion containing the same |
IE20050411A1 (en) * | 2005-06-17 | 2007-01-10 | Oriflame Global Technical Ct L | Cosmetic compositions containing lingonberry (vaccinium vitis idea) extracts |
JP2008156287A (en) * | 2006-12-25 | 2008-07-10 | Sanki Shoji Kk | Collagen production promoter |
WO2009003352A1 (en) * | 2007-07-04 | 2009-01-08 | Beijing Gingko Group | An extract of vaccinium vitis idaea l. and pharmaceutical composition, cosmetic composition, food and use thereof |
CN101543525B (en) * | 2008-03-28 | 2012-11-21 | 北京绿色金可生物技术股份有限公司 | Beauty composition containing vaccinium vitis-idaea extract and application thereof |
JP2009184997A (en) * | 2008-02-08 | 2009-08-20 | B & C Laboratories Inc | Collagen production promoter |
JP2011102270A (en) * | 2009-11-11 | 2011-05-26 | Rohto Pharmaceutical Co Ltd | Anti-saccharification agent |
JP4917180B1 (en) * | 2011-07-06 | 2012-04-18 | 株式会社 資生堂 | Skin improver for ingestion |
-
2011
- 2011-07-06 JP JP2011150116A patent/JP4917180B1/en active Active
-
2012
- 2012-05-31 CN CN201280026508.8A patent/CN103648514B/en not_active Expired - Fee Related
- 2012-05-31 WO PCT/JP2012/064211 patent/WO2013005514A1/en active Application Filing
- 2012-06-06 TW TW106103418A patent/TW201720424A/en unknown
- 2012-06-06 TW TW101120223A patent/TWI586376B/en active
Also Published As
Publication number | Publication date |
---|---|
JP2013014561A (en) | 2013-01-24 |
CN103648514B (en) | 2016-11-16 |
WO2013005514A1 (en) | 2013-01-10 |
CN103648514A (en) | 2014-03-19 |
TWI586376B (en) | 2017-06-11 |
JP4917180B1 (en) | 2012-04-18 |
TW201720424A (en) | 2017-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5468757B2 (en) | Composition having fibroblast proliferation promoting ability | |
JP4163631B2 (en) | Fermentation composition of spicy varieties of chili pepper and its use | |
TWI586376B (en) | Skin improvement methods and methods to promote collagen production | |
JP4658290B2 (en) | Fibroblast proliferating agent, cosmetic food and drink, and skin cosmetics | |
JP2010178736A (en) | Skin beauty-ameliorating agent, antioxidant, skin beauty-ameliorating composition, or cosmetic food/drink | |
EP2900336B1 (en) | Oral composition for reinforcing skin tolerance following topical administration of a retinoid compound | |
JP6235779B2 (en) | Folic acid-containing composition and method for stabilizing folic acid | |
JP2001316240A (en) | Collagen production promoter, estrogenic agent, skin cosmetic and food for beauty | |
WO2005094859A1 (en) | Agent improving moisture-retention function of skin | |
KR101474998B1 (en) | Composition comprising extracts of white tea for the care of skin wrinkle | |
JP2006311804A (en) | Skin-whitening composition formulated with zinc gluconate | |
JP2023118853A (en) | Anti-aging composition, anti-aging skin cosmetics and anti-aging food and drink | |
KR20170053536A (en) | Beverages for preventing respiratory disease and hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
JP2012067082A (en) | Oral composition | |
KR102100989B1 (en) | Method for producing inner beauty beverage using Chrysanthemum zawadskii and fermeted Rhus verniciflua | |
JP4413272B1 (en) | Hyaluronic acid production promoter | |
JP2020000226A (en) | candy | |
JP4608017B1 (en) | Pore reducing agent for oral consumption | |
JP2013116887A (en) | Oral hair growth agent | |
JP6397550B1 (en) | Constitution improver | |
JP7405543B2 (en) | Oral skin care composition | |
KR20180104960A (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
KR102012170B1 (en) | Composition comprising extracts of banana, cherry, and walnut for anti-skin aging | |
JP2005130710A (en) | Skin-beautifying food-and-drink composition | |
KR102032830B1 (en) | Fuctional food improving skin condition comprising rice bran extract |